Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain HBIO message board posts where the ticker symbol HBIO has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Tue, 08 Nov 2022
23:05:11 +0000
Harvard Bioscience (HBIO) Reports Q3 Loss, Misses Revenue Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -120% and 3.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Tue, 08 Nov 2022
21:01:00 +0000
Harvard Bioscience Announces Third Quarter 2022 Financial Results
“Fighting through challenging times while building the company and new technologies for the future.”HOLLISTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim Green, Chairman and CEO, said, "Impacted by a challenging summer, our third quarter revenues were $26.9 million, down 9% from the same quarter prior year. Growth of 6% in our cellular/molecular product reve
Mon, 07 Nov 2022
17:30:37 +0000
Shareholders in Harvard Bioscience (NASDAQ:HBIO) are in the red if they invested a year ago
Investing in stocks comes with the risk that the share price will fall. Anyone who held Harvard Bioscience, Inc...
Wed, 02 Nov 2022
21:15:00 +0000
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on November 8, 2022, and will hold a conference call to discuss the results at 4:30 p.m. Eastern Time. Participants who want to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who want to join the audio-only
Mon, 26 Sep 2022
14:23:04 +0000
When Will Harvard Bioscience, Inc. (NASDAQ:HBIO) Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Harvard Bioscience...
Wed, 24 Aug 2022
10:11:12 +0000
Great news for Harvard Bioscience, Inc. (NASDAQ:HBIO): Insiders acquired stock in large numbers last year
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Thu, 04 Aug 2022
02:48:00 +0000
Harvard Bioscience Announces Second Quarter 2022 Financial Results
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022. Jim Green, Chairman and CEO, said, "Our second quarter revenues were essentially flat compared to the prior year quarter as growth in our cellular/molecular product revenues were offset by reductions in pre-clinical revenues and an unfavorable foreign currency impact. Adjusted operating income for Q2 was lower th
Thu, 28 Jul 2022
14:39:19 +0000
What Type Of Shareholders Make Up Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Registry?
The big shareholder groups in Harvard Bioscience, Inc. ( NASDAQ:HBIO ) have power over the company. Large companies...
Tue, 26 Jul 2022
20:50:00 +0000
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on August 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who want to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who want to join the audio-only webcas
Wed, 15 Jun 2022
12:40:12 +0000
Are Options Traders Betting on a Big Move in Harvard Bioscience (HBIO) Stock?
Investors need to pay close attention to Harvard Bioscience (HBIO) stock based on the movements in the options market lately.
Sun, 29 May 2022
12:46:36 +0000
Investing in Harvard Bioscience (NASDAQ:HBIO) three years ago would have delivered you a 65% gain
Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders might understandably be very concerned that the share price has...
Mon, 16 May 2022
13:35:01 +0000
Harvard Bioscience (HBIO) Loses 35.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Harvard Bioscience (HBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Wed, 04 May 2022
12:25:12 +0000
Harvard Bioscience (HBIO) Q1 Earnings and Revenues Lag Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Wed, 04 May 2022
11:00:00 +0000
Harvard Bioscience Announces First Quarter 2022 Financial Results
•Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwinds HOLLISTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2022. Jim Green, Chairman and CEO, said, “Our revenue was up 7% on strength from North American sales despite the impact of lockdowns in China. Demand for our pre-clinical and cellular/molecular (CMT) products
Tue, 03 May 2022
21:25:09 +0000
PerkinElmer (PKI) Beats Q1 Earnings and Revenue Estimates
PerkinElmer (PKI) delivered earnings and revenue surprises of 15.87% and 6.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Tue, 26 Apr 2022
13:00:00 +0000
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
Company continues innovating preclinical tools used in new and ongoing small animal research and product development with SmartStudy™ SmartStudy Technology New Smart Study technology on the Buxco Inhalation System includes a modular tower, FinePointe software and controller for conducting small animal aerosol research. HOLLISTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) has introduced SmartStudy™, an innovative technology feature to its Buxco® Inhalation
Thu, 21 Apr 2022
20:05:00 +0000
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID #6757353. The conference call will
Tue, 19 Apr 2022
12:26:08 +0000
Harvard Bioscience, Inc. (NASDAQ:HBIO) Has Found A Path To Profitability
Harvard Bioscience, Inc. ( NASDAQ:HBIO ) is possibly approaching a major achievement in its business, so we would like...
Tue, 08 Mar 2022
12:00:00 +0000
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwindsGross margin improves to 59% in Q4 driven by strengthening product mix, improved operating leverage HOLLISTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the period ended December 31, 2021. Jim Green, Chairman and CEO said, “The positive trends we reported through the first three quarters of 2021 have carried t
Mon, 21 Feb 2022
21:30:00 +0000
Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET
HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID #1749525. The conference call



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "The most important thing I have learned at VF in the last 3 years reading all you smart peoples posts is money management. This is usually not taught by our parents." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2022, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards